Brief: DBP International Gets European Patent For Temodex / SI-053
20/02/2020 11:41
Feb 20 (Reuters) - Double Bond Pharmaceutical International
AB (publ) DBPHAb.TE :
* DBP INTERNATIONAL AB: EUROPEAN PATENT FOR TEMODEX / SI-053
IS
GRANTED
* PATENT APPROVAL PROVIDES PROTECTION FOR THE TECHNOLOGY AND
THE
PRODUCT IN 26 EUROPEAN PATENT ORGANIZATION (EPO) COUNTRIES AT
LEAST UNTIL 2036
Source text for Eikon: ID:nWkrSgsSn
Further company coverage: DBPHAb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University